Merck (MRK) Net Income Attributable to Noncontrolling Interests (2009 - 2026)
Merck's Net Income Attributable to Noncontrolling Interests came in at $2 million for Q3 2026, unchanged from $2 million a year earlier.
Powered by 
Analysis
Merck (MRK) Net Income Attributable to Noncontrolling Interests (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Merck reported Net Income Attributable to Noncontrolling Interests of -$4 million; for FY2025, it was $9 million, down 43.8% from FY2024.
- Net Income Attributable to Noncontrolling Interests carries a five-year compound annual growth rate of -9.7% (FY2020 to FY2025).
- Going back by year, Net Income Attributable to Noncontrolling Interests was $16 million in FY2024 (+33.3%), $12 million in FY2023 (+71.4%) and $7 million in FY2022.
- The five-year range for quarterly Net Income Attributable to Noncontrolling Interests is -$3 million (Q1 2026) to $6 million (Q1 2025).
- Year-over-year, Net Income Attributable to Noncontrolling Interests increased in 1 of the last four quarters, with an average decline of 28.3%.
- The fastest year-over-year change in Net Income Attributable to Noncontrolling Interests over five years came in Q2 2024 (growth of 100.0%), and the weakest in Q2 2025 (a decline of 83.3%).
- Business Quant data shows MRK's Net Income Attributable to Noncontrolling Interests at -$2 million (Q2 2026), -$3 million (Q1 2026) and -$1 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCI Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | - |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 2.00 Mn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 2.00 Mn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | -1.00 Mn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 10.00 Mn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.00 Mn |
| Jun 30, 2026 | -2.00 Mn |
| Mar 31, 2026 | -3.00 Mn |
| Dec 31, 2025 | -1.00 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 6.00 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 6.00 Mn |
| Mar 31, 2024 | 5.00 Mn |
| Sep 30, 2023 | 5.00 Mn |
| Jun 30, 2023 | 3.00 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | 1.00 Mn |
| Sep 30, 2022 | 5.00 Mn |
| Mar 31, 2021 | 7.00 Mn |
| Dec 31, 2020 | 3.00 Mn |
| Sep 30, 2020 | 4.00 Mn |
| Jun 30, 2020 | 8.00 Mn |
API Access
Merck Net Income Attributable to Noncontrolling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=MRK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "MRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=MRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();